CALTX.ST
Price:
$208
Market Cap:
$11.24B
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis,...[Read more]
Industry
Biotechnology
IPO Date
2018-06-29
Stock Exchange
STO
Ticker
CALTX.ST
According to Calliditas Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 11.45B. This represents a change of 55.12% compared to the average of 7.38B of the last 4 quarters.
The mean historical Enterprise Value of Calliditas Therapeutics AB (publ) over the last ten years is 3.63B. The current 11.45B Enterprise Value has changed 31.43% with respect to the historical average. Over the past ten years (40 quarters), CALTX.ST's Enterprise Value was at its highest in in the June 2024 quarter at 11.26B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
3.63B
Median
3.13B
Minimum
1.35B
Maximum
6.83B
Discovering the peaks and valleys of Calliditas Therapeutics AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 157.34%
Maximum Annual Enterprise Value = 6.83B
Minimum Annual Increase = -56.98%
Minimum Annual Enterprise Value = 1.35B
Year | Enterprise Value | Change |
---|---|---|
2023 | 6.83B | 55.81% |
2022 | 4.38B | -12.21% |
2021 | 4.99B | -5.34% |
2020 | 5.27B | 157.34% |
2019 | 2.05B | 28.84% |
2018 | 1.59B | 18.13% |
2017 | 1.35B | -56.98% |
2016 | 3.13B | 1.00% |
The current Enterprise Value of Calliditas Therapeutics AB (publ) (CALTX.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
5.40B
5-year avg
4.70B
10-year avg
3.63B
Calliditas Therapeutics AB (publ)’s Enterprise Value is greater than Oncopeptides AB (publ) (169.98M), less than BioArctic AB (publ) (12.41B), greater than Hansa Biopharma AB (publ) (2.61B), less than Camurus AB (publ) (32.97B), less than Bonesupport Holding AB (publ) (22.51B),
Company | Enterprise Value | Market cap |
---|---|---|
169.98M | $438.37M | |
12.41B | $12.84B | |
2.61B | $2.22B | |
32.97B | $35.52B | |
22.51B | $22.66B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calliditas Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Calliditas Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Calliditas Therapeutics AB (publ)'s Enterprise Value?
What is the highest Enterprise Value for Calliditas Therapeutics AB (publ) (CALTX.ST)?
What is the 3-year average Enterprise Value for Calliditas Therapeutics AB (publ) (CALTX.ST)?
What is the 5-year average Enterprise Value for Calliditas Therapeutics AB (publ) (CALTX.ST)?
How does the current Enterprise Value for Calliditas Therapeutics AB (publ) (CALTX.ST) compare to its historical average?